Clinical Trial Update: Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating cannabidiol in children and young adults with rare disease-associated severe epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Epilepsy, Rare Diseases | Phase 2 | Status: UNKNOWN